AngioDynamics Inc. Q2 Loss Decreases, Beats Estimates
AngioDynamics Inc. (ANGO) revealed Loss for second quarter that decreased from last year but beat the Street estimates. The ...
AngioDynamics: Fiscal Q2 Earnings Snapshot
AngioDynamics Inc. ANGO) on Wednesday reported a loss of $10.7 million in its fiscal second quarter. On a per-share basis, the Latham, New York-based company said it had a loss of 26 cents.
What To Expect From AngioDynamics Inc (ANGO) Q2 2025 Earnings
AngioDynamics Inc (NASDAQ:ANGO) is set to release its Q2 2025 earnings on Jan 8, 2025. The consensus estimate for Q2 2025 ...
Hosted on MSN28d
ANGO Stock Up Post FDA Nod for Prostate Tissue Ablation With NanoKnife
AngioDynamics, Inc. ANGO, yesterday, announced the receipt of the FDA’s 510(k) clearance for the NanoKnife System for prostate tissue ablation. The clearance for the NanoKnife System for ...
AngioDynamics to Host Virtual Event Showcasing the Innovative NanoKnife(TM) System
Attendees will gain insights into the NanoKnife System’s proprietary irreversible electroporation (IRE) technology and how it is poised to become the standard, function-preserving treatment for men ...
Vanguard10d
Michael Ango: Revolutionizing revenue assurance in the FCT
In August 2024, President Bola Ahmed Tinubu appointed Mr. Michael Hadi Ango as the Acting Executive Chairman of the Federal ...
TheCable8d
Michael Ango: Revolutionising revenue assurance in the FCT
In a bold move to improve efficiency, Ango initiated the takeover of revenue collection for the FCT’s area councils by the FCT-IRS. This centralization effort is designed to minimize leakages and ...